Correlation Between Unicycive Therapeutics and Tempest Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Tempest Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Tempest Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Tempest Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Tempest Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Tempest Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Tempest Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Tempest Therapeutics
-0.69 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Unicycive and Tempest is -0.69. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Tempest Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tempest Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Tempest Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tempest Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Tempest Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Tempest Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 10.88 times less return on investment than Tempest Therapeutics. But when comparing it to its historical volatility, Unicycive Therapeutics is 8.17 times less risky than Tempest Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Tempest Therapeutics is currently generating about 0.04 of returns per unit of risk over similar time horizon. If you would invest 64.00 in Tempest Therapeutics on September 12, 2024 and sell it today you would earn a total of 24.60 from holding Tempest Therapeutics or generate 38.44% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Unicycive Therapeutics vs. Tempest Therapeutics
Performance |
Timeline |
Unicycive Therapeutics |
Tempest Therapeutics |
Unicycive Therapeutics and Tempest Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Unicycive Therapeutics and Tempest Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Tempest Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Tempest Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tempest Therapeutics will offset losses from the drop in Tempest Therapeutics' long position.Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
Tempest Therapeutics vs. Indaptus Therapeutics | Tempest Therapeutics vs. Rezolute | Tempest Therapeutics vs. Forte Biosciences | Tempest Therapeutics vs. Sana Biotechnology |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Other Complementary Tools
Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
CEOs Directory Screen CEOs from public companies around the world | |
Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |